According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, and the effects are impressive. A 2022 study found that people who received weekly semaglutide injections lost an average of about 15 pounds after three months.

Weight Watchers files for bankruptcy to help compete with Ozempic - Once boasting up to five million subscribers and backed by the likes of Oprah Winfrey, the company is now trying to shed debt and re

WeightWatchers has filed for bankruptcy as more Americans turn to weight loss drugs to slim down.